Plunkett Research Online: Cyclacel Pharmaceuticals Inc.

CYCLACEL PHARMACEUTICALS INC. (CYCC:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biopharmaceutical company.....

Cyclacel Pharmaceuticals Inc.
Ticker: CYCC
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 908 517-7330
Address: 200 Connell Drive
Suite 1500
Berkeley Heights, NJ 07922 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Spiro Rombotis CEO/President/Director
Paul McBarron CFO/Chief Accounting Officer/COO/Director/Executive VP, Divisional/Secretary
See More
A biopharmaceutical company.....See More See More

Auditor: RSM US LLP
Legal Advisor: Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: